Estimating and determining the effect of a therapy on tumor dynamics by means of a modified Gompertz diffusion
Giuseppina Albano1, Virginia Giorno2, Patricia Román-Román3
1Dip. di Scienze Economiche e Statistiche, Università di Salerno, Italy.
Abstract:
A modified Gompertz diffusion process is considered to model tumor dynamics. The infinitesimal mean of this process includes non-homogeneous terms describing the effect of therapy treatments able to modify the natural growth rate of the process. Specifically, therapies with an effect on cell growth and/or cell death are assumed to modify the birth and death parameters of the process. This paper proposes a methodology to estimate the time-dependent functions representing the effect of a therapy when one of the functions is known or can be previously estimated. This is the case of therapies that are jointly applied, when experimental data are available from either an untreated control group or from groups treated with single and combined therapies. Moreover, this procedure allows us to establish the nature (or, at least, the prevalent effect) of a single therapy in vivo. To accomplish this, we suggest a criterion based on the Kullback-Leibler divergence (or relative entropy). Some simulation studies are performed and an application to real data is presented.
Insights
This study models tumor growth using a modified Gompertz diffusion process, estimating therapy effects on cell growth and death. A new method determines therapy impact using relative entropy, applicable to combined treatments and single-agent analysis.
Area of Science:
- Mathematical Biology
- Biostatistics
- Pharmacodynamics
Background:
- Tumor growth dynamics are complex and influenced by various factors, including therapeutic interventions.
- Modeling tumor progression requires understanding the interplay between cell proliferation and death rates.
- Existing models may not fully capture the nuanced effects of combined therapies on tumor dynamics.
Purpose of the Study:
- To develop a methodology for estimating time-dependent therapy effects on tumor dynamics using a modified Gompertz diffusion process.
- To enable the estimation of individual therapy functions when combined treatment data is available.
- To determine the predominant in vivo effect (growth or death) of a single therapeutic agent.
Main Methods:
- Utilized a modified Gompertz diffusion process incorporating non-homogeneous terms for therapy effects.
- Proposed a method to estimate time-dependent functions representing therapy impact on birth and death parameters.
- Employed Kullback-Leibler divergence (relative entropy) as a criterion for analyzing therapy effects.
Main Results:
- Successfully developed a methodology to estimate therapy-induced changes in tumor growth and death rates.
- Demonstrated the ability to infer individual therapy effects from data of combined treatments or control groups.
- The Kullback-Leibler divergence criterion proved effective in distinguishing therapy impacts.
Conclusions:
- The proposed methodology offers a robust framework for analyzing tumor dynamics under therapeutic intervention.
- This approach facilitates the characterization of single-agent therapy effects in vivo.
- The study provides valuable tools for pharmacodynamic modeling and treatment optimization.
More Related Videos
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
10:23Author Spotlight: Computing the Effects of a Local Radiofrequency Hyperthermia Intervention on Tumor Biomechanics
Published on: December 1, 2023
Related Concept Videos
Modeling with Differential Equations
Exponential Equations for Modeling Growth
Pharmacodynamic Models: Logarithmic Concentration–Effect Model
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Pharmacodynamic Models: Emax Drug–Concentration Effect Model
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
